Investcare S.A.

Business and other management consultancy activities

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2018-05-30
Share capital
1,420,000.00 PLN
Average employment (people)
15 (2025)
Activity description

Investcare is a pharmaceutical group that includes MEDI&MORE, a wholesaler serving over 3,000 pharmacies with more than 20,000 products, and the 4 Pory Roku partner pharmacy chain, with 240 locations across 16 provinces in Poland. Its medicare.pl portal covers health and beauty and enables prescription reservations and free delivery. Group company Biocanto produces and distributes dietary supplements and medical products.

Registered address
ul. Białobrzeska 45, 41-409 Mysłowice, Poland
Email
Phone
Social media
Electronic delivery address
AE:PL-71162-93418-ICAUB-19

Financials

Revenue history (in k)

From the notes

Profit allocationRetained in reserve capital
Revenue structureUsługi IT, HR, PR, obsługi prawnej i controllingu
Management board pay$23,606
Merger or transformationYes
Shareholders
  • osoba fizyczna 90%
  • pozostali 10%
Shares in other companies
  • Biomed Lublin SA

Filing timeliness

2 of 6 financial statements were filed late (the longest delay 49 days for 2025). All were audited by a statutory auditor.

  • 202502/09/2026
  • 202401/07/2025
  • 202308/07/2024
  • 202203/07/2023
  • 202125/08/2022
  • 202027/09/2021
Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2025.

City · Mysłowice115 / 439
Top 26%
Voivodeship · Śląskie8,140 / 33,148
Top 25%
Country · Poland75,072 / 297,069
Top 25%

Results vs industry

Revenue
This companyUSD 1.44mMedianUSD 66.54kAverageUSD 1.21m
Net profit
This companyUSD 3.77kMedianUSD 1.81kAverageUSD 72.88k
Operating costs
This companyUSD 1.40mMedianUSD 50.39kAverageUSD 1.02m
Assets
This companyUSD 4.00mMedianUSD 69.52kAverageUSD 2.58m

Offer

Websites

  • grupainvestcare.plInvestcare Grupa Farmaceutyczna – MEDI&MORE | Medicare.pl | Sieć 4 Pory Roku
    WordPress 6.9ElementorGoogle AnalyticsGoogle Tag ManagerLiteSpeed

Job offers

The company has its own careers page: grupainvestcare.pl/kariera-praca-staze.

Authorized Representatives

Agata Stanisława Empfinger age 49 – Attorney-in-fact (sole)
Ewelina Anna Górska age 51 – Attorney-in-fact (joint)
Anna Palka-Porwit age 49 – Attorney-in-fact (sole)
Joanna Besler age 53 – Attorney-in-fact (joint)
Dariusz Jan Kucowicz age 61 – President of the Management Board

Manner of representation

In the case of a one-person management board, the company is represented by a member of the management board independently or by two commercial proxies jointly. In the case of a multi-member management board, the company is represented by two members of the management board jointly or by one member of the management board jointly with a commercial proxy or by two commercial proxies jointly.

Supervisory board

Jarosław Paweł Błaszczak age 53 – Supervisory Board Member
Bożena Kwaśniak age 68 – Supervisory Board Member
Piotr Michał Broda age 61 – Supervisory Board Member
Grzegorz Sadurski age 39 – Supervisory Board Member

Beneficial owners

Person

Subsidiaries

NameStake
Allecco sp. z o.o.
99.9988%
Biocanto sp. z o.o.
99.9756%
Mediqmedia sp. z o.o.
99.9%

Capital group

The company is the parent company of a corporate group.

NameCountry
Pharmacy SolutionsPoland

Bank accounts

Registered as a VAT taxpayer on 2018-07-14.

Debt

No entries in the National Debtors Register (KRZ).

Real estate

TypeAmount
Buildings and premises
PLN 159.8K
Investment property
PLN 122.3K

MSiG notices

6 notices recorded in the Court and Commercial Gazette (MSiG).

Publication dateEvent
Mar 6, 2025Shareholders' meeting convened
Oct 8, 2024Shareholders' meeting convened
Jun 12, 2024Shareholders' meeting convened
Apr 10, 2024Shareholders' meeting convened
Oct 3, 2023Shareholders' meeting convened

Public aid

PurposeGross amount
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
–
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
–
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
–

Competitors

Name
Przedsiębiorstwo Zaopatrzenia Farmaceutycznego Cefarm-Kielce S.A.
Interpharma sp. z o.o.
Trumedico Pl sp. z o.o. + limited partnership
Vipado sp. z o.o.
Synergy Trading sp. z o.o.
Solinea Pharma sp. z o.o.
Kleemed Pharmaceuticals Poland sp. z o.o.
Sincofarm sp. z o.o.
Bonopharm sp. z o.o.
Biocanto Pharma sp. z o.o.

Change history

DateEvent
2021-12-09Share capital increase
2019-07-01Share capital increase
2018-05-30Entered in the register

FAQ

Last updated: 2026-10-07